Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Advanced Micro Devices, Inc. continues to show strong growth, especially in AI and data center segments. Learn more about AMD ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Sanmina's $3B ZT Systems acquisition boosts AI presence, nearly doubles revenue, and could add $1+ to EPS. Read the latest ...

Advanced Micro Devices (AMD) has been on a tear lately. Over the past month, the stock has surged about 32%, with a healthy 6 ...

US stock futures slide after Moodys downgraded the countrys credit rating from “Aaa” to “Aa1,” raising alarm over Americas ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

Poor breadth is mirrored in the percentage of total shares traded that are falling versus those rising. On the NYSE, ...

Intel Corporation, Qualcomm Incorporated, Advanced Micro Devices Inc. Read 's Market Analysis on Investing.com ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

Advanced Micro Devices Inc. (NASDAQ: AMD) shares were up nearly 2% on Wednesday before pulling back as the broader market ...

Among the 20 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on 10 “Strong Buy” ratings, one “Moderate Buy,” and nine “Holds.” The ...